Invesco
CAPR icon

Invesco’s Capricor Therapeutics CAPR Stock Holding History

Invesco’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Sell
29,552
-155,820
-84% -$4.72M ﹤0.01% 3089
2026
Q1 		$5.64M Buy
185,372
+171,751
+1,261% +$4.58M ﹤0.01% 2143
2025
Q4 		$393K Sell
13,621
-34
-0.2% -$444 ﹤0.01% 3285
2025
Q3 		$98.5K Sell
13,655
-869
-6% -$6.4K ﹤0.01% 3687
2025
Q2 		$144K Buy
14,524
+276
+2% +$2.92K ﹤0.01% 3596
2025
Q1 		$135K Sell
14,248
-430
-3% -$5.97K ﹤0.01% 3588
2024
Q4 		$203K Buy
14,678
+2,500
+21% +$43.8K ﹤0.01% 3508
2024
Q3 		$185K Buy
12,178
+44
+0.4% +$218 ﹤0.01% 3531
2024
Q2 		$57.9K Buy
+12,134
New +$67.7K ﹤0.01% 3806

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco's CAPR Position: Q2 2026 in Review

Invesco reduced its Capricor Therapeutics (CAPR) stake by 84% in Q2 2026, selling an estimated $4.72M and leaving 29,552 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #3089.

Invesco first reported a position in CAPR in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.64M in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Invesco held 29,552 shares of Capricor Therapeutics worth $712K as of Q2 2026.
  • Invesco sold 155,820 Capricor Therapeutics shares in Q2 2026, an estimated $4.72M.
  • Capricor Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3089 holding.
  • Invesco first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Invesco's Capricor Therapeutics position peaked at $5.64M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.